Low HDL-C levels are commonly associated with increasing a person's risk of developing cardiovascular disease. However, a new study in the Journal of the American College of Cardiology suggests this may not be the case for all patient populations. 

Two specialists with Hackensack University Medical Center in New Jersey performed the procedure. The patient, a 71-year-old woman, is doing well. 

The companies were given 15 days to provide an adequate response to the FDA's warning. The agency said its next step could include legal action. 

Telehealth can provide significant value when it comes to managing and monitoring patients with CVD or suspected CVD. A new scientific statement from the American Heart Association explores the latest details on this evolving treatment option. 

However, researchers noted, there is still considerable room for improvement.

The ACC is especially excited to see what VR training can do to bring minimally invasive interventional procedures to more and more patients throughout the United States.

Updated Twitter policies have helped online pranksters cause mischief in recent days, including one specific user who impersonated Eli Lilly and Company and posted that insulin was now free. Lilly's CEO has now commented on the fake tweet read 'round the world—and what it could mean for the company going forward.